BioPartnering North America

BioPartnering North America

February 17, 2010 12:00 ET

BioPartnering North America™ (BPN) Sets the Stage for Partnering in 2010

Conference Creates Significant Partnership Opportunities

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Feb. 17, 2010) - Technology Vision Group LLC (TVG) is pleased to announce that the 8th annual BioPartnering North America (BPN) conference has had yet another successful year, setting the stage for TVG's 2010 international conference schedule that seeks to build a global life science network.

BPN 2010 brought together international leaders from the biotechnology, pharmaceutical and financial industries with over 800 delegates from 490 companies representing 26 countries attending the conference, allowing delegates to engage in over 2,200 face-to-face meetings and helping them expand their international business opportunities. The success of BPN means that to accommodate the meeting's growing popularity; next year's conference will take place in the Vancouver Convention Centre.

Dr. Robert Lee Kilpatrick, Partner of Technology Vision Group commented:

"The 8th Annual BioPartnering North America event was successful because it continues to deliver value to life science companies seeking partnerships and other kinds of business relationships. The event attracted companies and delegations from 26 countries with strong support from France, Italy, Spain, UK, India, Canada and the United States.

BioPartnering North America is first and foremost a global event. Looking ahead to 2011 TVG and its partners are on course to substantially increase global participation and with this expansion in mind we are planning to move to the Vancouver Convention Centre to accommodate an increase in delegate attendance."

BPN offered delegates the opportunity to partake in a variety of interactive leadership sessions regarding cutting-edge themes of interest with companies such as OncoMed Pharmaceuticals and GlaxoSmithKline. Other highlights of the conference included the discussion of deal making with big pharma, business opportunities for the industry in Asia and the future of the industry after the global credit crunch. In addition, the conference showcased some of the leading biotechnology companies of the moment in podium presentations, where delegates were able to introduce their companies, ensuring maximum exposure for their partnering goals and objectives.

Karimah Es Sabar, President of LifeSciences British Columbia commented:

"BioPartnering North America 2010 was once again a huge success and LifeSciences BC was proud to co-produce this world-class event. By bringing the biotech world here to British Columbia, it not only allows partners from all corners of the globe to meet one another and explore mutual opportunities, but also allows us as the local industry association, a chance to showcase British Columbia's research and business excellence. We look forward to welcoming all of our international partners and colleagues back to Vancouver in 2011, and further building the global networks we all need to succeed."

2010: A Year of Global Partnering Conferences

TVG has created an extensive network of innovative partnering events over the course of 2010, each of which TVG is committed to making as successful as BPN.

The TVG conference network is focused on facilitating business development, providing an open and vibrant format that allowing delegates to pre-book meetings and share agendas before the event date, via TVG's unique partnering tool biopartnering.com.

There are currently 5 other international conferences lined up for the remainder of 2010:

  • C21 BioVentures™ (C21) in Napa, CA, USA: May 25-27, 2010
    For more details and to register for our Early Bird rate please go to: www.techvision.com/c21
  • BioPartnering India™ (BPI) in Bangalore, India: June 2-4, 2010
    For more details and to register please go to: www.techvision.com/bpi
  • BioPartnering Latin America™ (BPL) in Rio de Janeiro, Brazil:
    September 19-21, 2010. For more details and to register please go to: www.techvision.com/bpl
  • BioPartnering Europe™ (BPE) in London, UK: October 10-12, 2010
    For more information please go to: www.techvision.com/bpe
  • BioPartnering China™ (BPC) in Shanghai, China:
    October 31- November 2, 2010. For more information please go to: www.techvision.com/bpc

Do not miss out on the endless partnering opportunities offered at TVG conferences.

For more information regarding TVG and their global conferences, please visit: www.techvision.com

Producers

TVG and LifeSciences British Columbia

Hosts

BIOTECanada and BioAlberta

2010 Podium Presenters (As of 4 January 2010)

AAIPharma Inc.; ACT Biotech; Agere Pharmaceuticals; Alligator Bioscience AB; Allon Therapeutics Inc.; Allostera Pharma Inc.; Allphase Clinical Research Inc.; Alphora Research Inc.; Alsace BioValley; Ambit Biosciences; Angiochem; Aquinox Pharmaceuticals Inc.; Araclon Biotech; Augurex Life Sciences Corp.; AVOGADRO; Cellvax; Conformetrix; Congenix LLP; Crown Bioscience Inc; CYTOO cell architects; Cytovance Biologics, Inc.; Daiichi Sankyo Inc.; Debiopharm SA; DSM Biologics; DSM BIOSOLUTIONS; Elan Drug Technologies; Emerald BioStructures; Emmaus Medical, Inc.; Eurand, Inc.; EuraSante; Eurofins-Adme Bioanalyses; Forma Therapeutics, Inc.; GlobalTox; i3 CanReg; ImmunGene, Inc.; Immunovaccine Inc.; Inimex Pharmaceuticals, Inc.; Inovio Biomedical Corporation; iPierian; KAI Pharmaceuticals Inc.; LEO Pharma A/S; London Genetics Ltd; Medicago Inc.; Metabolys; NDA Regulatory Service AB; Nektar Therapeutics; NeuMedics Inc.; NicOx SA; Novalix; Novozymes; Oncodesign; Oncolytics Biotech Inc.; Ora, Inc.; Otonomy, Inc.; OxyPharma; PATH; Pearl Therapeutics, Inc.; PhysioStim; Plant Advanced Technologies; PlantForm; PolyMedix Inc.; Porsolt & Partners Pharmacology; Prestwick Chemical; Profectus BioSciences Inc.; ProtAffin Biotechnologie AG; PX'Therapeutics; Rose Pharma A/S; Sandoz GmbH; Sernova Corp; Shanghai Medicilon Inc.; Sirona Biochem; Skunkwerks Software Ltd; SuperGen Inc.; Synergy Pharmaceuticals; Teva Pharmaceutical Industries Ltd.; TFChem; Topica Pharmaceuticals; University of Manitoba - Technology Transfer Office; Vakzine Projekt Management GmbH; Valocor Therapeutics; Vifor Pharma; Vivalis; Xencor, Inc.; XenTech; YM BioSciences Inc.; Zymeworks

Exhibitors (As of 4 January 2010)

Alphora Research Inc.; CIRION Clinical Trial Services; Deloitte; Department of Biotechnology and Confederation of Indian Industry; French Trade Commission - UBIFRANCE; Globe Laboratories Inc; Italian Trade Commission; Korea International Trade Association (KITA); Pharmatek Laboratories, Inc.; Piramal Healthcare; PROOF Centre of Excellence; Silence Therapeutics AG; Zoomedia

Sponsors

Premium

AstraZeneca

Platinum

Deloitte

Gold

British Columbia Innovation Council; Crucell; Department of Biotechnology and Confederation of Indian Industry; Ferghana Partners Group; French Trade Commission - UBIFRANCE; Merck & Co., Inc.; OncoMed Pharmaceuticals; Roche

Silver

Anapharm / PharmaNet; BioAlberta; Bristol-Myers Squibb Company; Cooley Godward Kronish; Farris, Vaughan, Wills & Murphy; Gowling Lafleur Henderson; Italian Trade Commission; PricewaterhouseCoopers

Conference Sponsors

Genome British Columbia; Pfizer; UK Trade & Investment (Canada)

Conference Supporters

Naturejobs; San Jose BioCenter

Media Sponsors

BusinessWire; Citigate Dewe Rogerson; Marketwire; Nature Publishing Group; Pharmalicensing; Zoomedia

Media Supporters

BioBusiness; Biotechnology Focus; BioWorld Today; Contact Canada; Current Partnering; European Biopharmaceutical Review; BioCentury; CEO Clips, Biotech Finances

Regional Affiliates

APBio; AusBiotech; BIOCOM; BioIndustry Association (BIA); BioMelbourne; BioNova; Canada's Venture Capital & Private Equity Association (CVCA); ERBI; European Federation of Biotechnology; General Biologic; Life Science Association of Manitoba (LSAM); Netherlands' Biotech Industry Association (NIABA); Prince Edward Island BioAlliance; Queensland Clinical Trials Network Inc. (QCTN); Swiss Biotech; The Biotechnology Initiative

Contact Information